top of page



Research news


Prasinezumab: A New Hope for Parkinson’s Disease?
Prasinezumab is a new medicine in clinical trials that targets alpha-synuclein, with the aim of slowing Parkinson’s progression. While key trials did not meet their primary goals, encouraging signals keep scientific interest alive.
Dec 51 min read
bottom of page